IPSC vs V
Century Therapeutics Inc (IPSC) versus Visa Inc. Class A (V) — a side-by-side from cached financials, not a winner call.
Century Therapeutics Inc (IPSC) is a biotechnology company listed on US.
Visa Inc. Class A (V) is a credit services company listed on US. It is led by Ryan McInerney.
Latest reported IPSC revenue for 2024-12-31 was $6.6M. Net income was -$126.6M. Revenue was up 194.8% from 2023-12-31 to 2024-12-31. IPSC currently screens at market cap $47.8M.
Latest reported V revenue for 2025-09-30 was $40.00B. Net income was $20.06B. V currently screens at market cap $659.78B and trailing P/E 33.5.
IPSC currently screens at market cap $47.8M. V currently screens at market cap $659.78B and trailing P/E 33.5.
Not investment advice. Open the IPSC and V stock pages for the full models.
Not investment advice.